A more complex HIV family tree discovered

Adding another component into an already complicated effort to identify weaknesses within HIV, a team of Los Alamos scientists discovered that HIV variation in the human population is driven by more than a person’s immune response.

The common ancestry of HIV strains explains many of the viral mutational patterns that previously gave rise to a belief that the virus adapted in predictable ways within people with similar immune systems. While human immune responses do drive viral evolution, these recent findings show that the story is more complex, providing a more detailed, accurate picture of HIV’s evolution and the need for a new path to the development of a viable vaccine.

In a paper published in the March 16 issue of Science Magazine, Los Alamos researchers Tanmoy Bhattacharya, Marcus Daniel, and Bette Korber –- along with their colleagues –- explain that the sequence of a virus is dictated not only by the way in which it mutates to escape detection by a host’s immune system, but also by the common source and evolutionary track of the virus itself.

“In biology or any other system of evolving entities, when we try to find the relation between any characteristics and a mutational pattern –- like a viral change and the immune system of the person it finds itself in –- one should never forget that the organisms haven't arisen at random but are descended from a common ancestor,” said Bhattacharya.

Because viruses are similar due to common descent alone -– i.e. HIV transmitted among a group who shared needles or individuals infected via sexual transmission from each other -– Bhattacharya asserts that the common source, rather than just the similarities in the hosts’ genetic structures, may account for many of the observed similarities among the viruses. He said population studies of this kind, in which scientists were investing, are probably not a good way to find all the parts of the virus visible to the immune system.

Conversely, the new research methodology, which accounts for such viral lineages, allows scientists to better understand how HIV adapts in the context of the human immune system. “The virus is changing in different people in different ways. This paper’s main point is basic biology -- understanding the relationship between host and virus,” said Korber.

“Also, it introduces new methodology for looking for correlations between viral mutations and a viral characteristic (like immune escape), taking into account a good model of the virus' evolutionary history,” she said.

The researchers predict that this new discovery will have a major impact on
vaccine design. “Since HIV escapes the immune system of the human host by mutation, and the virus finds multiple ways of escaping immune recognition, our findings have practical implications for defining relevant variants for inclusion in vaccine antigens,” said Korber.

In addition, as the research presented shows that scientists cannot find all the regions of the virus (called epitopes) that are useful targets for the immune system without expensive patient by patient analysis -— and the virus finds multiple ways of evading the immune system -— a vaccine has to be versatile enough to address these complications. In a previous paper published on December 24, 2006 in Nature Medicine, Lab scientist William Fischer, Korber, Bhattacharya, and team offer a vaccine model based on a mosaic of synthetic proteins that subsequently address these factors.

“We present ideas of how to deal with the situation of not knowing where the epitopes are and the virus having multiple escape paths,” said Bhattacharya.

Additionally, according to Korber and Bhattacharya, their findings are not limited to HIV and can be applied in researching other viruses like Hepatitis.

“The methods we developed are of generality and will be useful in studies whenever we want to know whether some property of the virus (like which person it was extracted from, when in the infection cycle it was found, etc.) is to be correlated with the genetic sequence data obtained for it,” said Bhattacharya. “It is this generality, and the basic biology, which actually makes the paper important.”

Source: Los Alamos National Laboratory

Related stories:

Scientists identify gene that may make humans more vulnerable to pulmonary tuberculosis
Researchers from the Genome Institute of Singapore (GIS) and its collaborators have now identified for the first time a new gene that may confer susceptibility to pulmonary tuberculosis. Their findings, published October 10 in the open access journal PLoS Genetics, reported that a gene named Toll-like receptor 8 (TLR8), previously shown only to recognize some factors from viruses such as the human immunodeficiency virus (HIV), has a probable role in human susceptibility to Mycobacterium tuberculosis infections. The results from the study also found that males are more susceptible than females.
Scientists Find First Immune Responses to HIV Infection Ineffective
(PhysOrg.com) -- Scientists have identified the very first antibodies to appear in the wake of HIV infection and have concluded that they are virtually impotent in mounting a meaningful defense against the invading virus.
Gene with probable role in human susceptibility to pulmonary tuberculosis identified
A new gene that may confer susceptibility to pulmonary tuberculosis has been identified by Genome Institute of Singapore (GIS) researchers and their collaborators in The Netherlands, Indonesia, United Kingdom, and the Russian Federation.
HIV drug maraviroc effective for drug-resistant patients
As many as one quarter of HIV patients have drug resistance, limiting their treatment options and raising their risk for AIDS and death. Now, maraviroc, the first of a new class of HIV drugs called CCR5 receptor antagonists, has been shown to be effective over 48 weeks for drug-resistant patients with R5 HIV-1, a variation of the virus found in more than half of HIV-infected patients.
A DNA-based vaccine shows promise against avian flu
(PhysOrg.com) -- Though it has fallen from the headlines, a global pandemic caused by bird flu still has the United States’ Centers for Disease Control and Prevention on high alert. Yet, to date, the only vaccines that have proven even semi-effective are produced in chicken eggs, take five to six months to prepare and act against a single variant of the H5N1 virus, which mutates incredibly quickly. Now, new research by scientists in New York and Taiwan has led to a vaccine with the potential to stop most strains of H5N1 flu viruses in their tracks.
Existing anti-obesity drugs may be effective against flu, hepatitis and HIV
Viruses dramatically increase cellular metabolism, and existing anti-obesity drugs may represent a new way to block these metabolic changes and inhibit viral infection, according to a study published today in the journal Nature Biotechnology.
Scientists unmask key HIV protein, open door for more powerful AIDS drugs
University of Michigan scientists have provided the most detailed picture yet of a key HIV accessory protein that foils the body's normal immune response. Based on the findings, which appear online in the journal PLoS Pathogens, the team is searching for new drugs that may someday allow infected people to be cured and no longer need today's AIDS drugs for a lifetime.
Study examines cost-effectiveness of HIV monitoring strategy in countries with limited resources
In a computer-based model evaluating the benefits and costs of three types of HIV disease monitoring strategies, early initiation of antiretroviral therapy and monitoring using the CD4 count, a measure of immune system function, instead of based on symptoms appear to provide health benefits in low- and middle-income countries, according to a report in the September 22 issue of Archives of Internal Medicine.

News discussion:

Medicine & Health news